Biomerica Reports Fiscal 2021 Year End Results
August 27, 2021 20:37 ET
|
Biomerica, Inc.
Revenues increase 7.6% for fiscal 2021 vs fiscal 2020.InFoods® IBS Endpoint Trial expected to be fully enrolled in less than 2 weeks.Biomerica receives multiple notices of allowance for patents...
Biomerica Announces Notice of Allowance for Patent on Product used to Diagnose and Treat Depression
August 11, 2021 08:19 ET
|
Biomerica, Inc.
Hundreds of millions of people worldwide suffer from depression IRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today that the Japanese Patent Office has...
Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test
August 05, 2021 08:19 ET
|
Biomerica, Inc.
Digital Health Advertising and Social Media Campaigns launching alongside new siteCurrently in discussion with major retailers to increase distribution of EZ Detect™ Colon Disease Test IRVINE,...
Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™
June 24, 2021 08:19 ET
|
Biomerica, Inc.
Prevalence of H. pylori infection in the United States is approximately 35% to 40% of the population IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced...
Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment
June 15, 2021 08:19 ET
|
Biomerica, Inc.
IBS is one of the most important gastrointestinal disorders in Mexico, with a prevalence of around 16% [1] (approximately 20 million patients)Broadens InFoods® global patent coverage with recently...
Biomerica to Participate in Upcoming Investor Conferences
June 04, 2021 08:00 ET
|
Biomerica, Inc.
IRVINE, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced that it will be participating in two upcoming...
Biomerica’s Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab
May 11, 2021 08:19 ET
|
Biomerica, Inc.
Less invasive nasal swab taken from front opening of the nose is more comfortable for patientsTest can be performed by doctors, school and company nurses, and medical assistants, in any location...
Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020
April 15, 2021 10:31 ET
|
Biomerica, Inc.
Sales increase driven by first sales of COVID-19 Antigen Rapid Test in Europe after January 2021 CE Mark approval Awarded two new patents for InFoods® diagnostic guided therapy technology, including...
Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
January 15, 2021 09:27 ET
|
Biomerica, Inc.
Biomerica expects completion of enrollment of its Irritable Bowel Syndrome Diagnostic-Guided Therapy clinical trial by end of April, 2021 FDA actively reviewing Company’s EUA submission for its...
Biomerica’s Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark
January 12, 2021 08:19 ET
|
Biomerica, Inc.
Biomerica receives first orders and plans to ship tests in coming weeks Clinical studies demonstrated an overall performance of 94.7% positive agreement (sensitivity) and 99.7% negative agreement...